Results 171 to 180 of about 262,262 (298)

Survival From Out‐of‐Hospital Cardiac Arrest: Are We Beginning to See Progress?

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
Stuart Berger
doaj   +1 more source

Direct in‐scope suction (DISS) ureteroscopy: techniques, outcomes and future directions

open access: yesBJU International, EarlyView.
Objective To provide an overview of direct in‐scope suction (DISS) ureteroscopy, an emerging technology that integrates suction directly into the ureteroscope with the aim of enhancing stone clearance, improving visualisation, and reducing intrarenal pressure during ureteroscopic stone surgery.
Parth U. Patel   +6 more
wiley   +1 more source

Assessing KAP of primary care physicians in Lebanon in screening for sudden cardiac arrest in youth. [PDF]

open access: yesMedicine (Baltimore)
El Ghazawi A   +10 more
europepmc   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

Replacement fibrosis, left ventricular ejection fraction and sudden cardiac death in patients after myocardial infarction: a mediation analysis. [PDF]

open access: yesOpen Heart
Zhou P   +17 more
europepmc   +1 more source

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Novel heart failure (HF) pharmacotherapies, including angiotensin receptor‐neprilysin inhibitor (ARNI) and sodium‐glucose cotransporter 2 inhibitors (SGLT2is), may confer cardiovascular benefits by attenuating myocardial fibrosis. However, direct evidence from human failing myocardial samples is limited.
Dávid Nagy   +10 more
wiley   +1 more source

Sudden cardiac death and the role of postmortem genetic testing in unexplained cases. [PDF]

open access: yesIndian Pacing Electrophysiol J
Rajan D   +3 more
europepmc   +1 more source

Mitochondrial Ca2+ overload is a pivotal risk factor for lethal ventricular arrhythmias due to the oxidation of mitochondrial respirasome and energetic failure

open access: yesBritish Journal of Pharmacology, EarlyView.
The data that support the findings of this study are available from the corresponding author upon reasonable request. Some data may not be made available because of privacy or ethical restrictions. Background and Purpose Ventricular arrhythmias are a leading cause of death among patients with cardiovascular diseases and are associated with elevated ...
Felipe de Jesús Salazar‐Ramírez   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy